Clinical Trial Update: Pharmacokinetics and Safety of Transdermal Megestrol Acetate [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the pharmacokinetics and safety of transdermal Megestrol Acetate for cachexia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Cachexia | Phase 4 | Status: WITHDRAWN